Lv1
38 积分 2024-05-21 加入
Bispecifics: The future of therapeutic antibodies
7天前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
15天前
已完结
Preclinical Development of GR2002 , a Novel Anti‐ TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects
1个月前
已完结
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Rα with a Biparatopic nanobody
1个月前
已完结
Lysosome-targeting chimeras evolve
1个月前
已完结
Artificial intelligence in antibody–drug conjugate development
2个月前
已完结
Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair
2个月前
已完结
One‐Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand‐Directed Acylation Strategy
3个月前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
3个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
5个月前
已完结
皖公网安备34019202002308
